Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)

Resource type
Journal Article
Authors/contributors
Title
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021)
Publication
Journal of Clinical Microbiology
Volume
62
Issue
2
Pages
e01141-23
Date
2024-01-09
Accessed
3/23/24, 4:11 PM
Library Catalog
Extra
Publisher: American Society for Microbiology
Citation
Pfaller, M. A., Carvalhaes, C. G., Rhomberg, P. R., Desphande, L. M., & Castanheira, M. (2024). Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017–2021). Journal of Clinical Microbiology, 62(2), e01141-23. https://doi.org/10.1128/jcm.01141-23